Robeco Institutional Asset Management B.V. Has $233.35 Million Stock Position in CVS Health Corporation $CVS

Robeco Institutional Asset Management B.V. raised its position in CVS Health Corporation (NYSE:CVS) by 16.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 3,095,243 shares of the pharmacy operator’s stock after purchasing an additional 432,132 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in CVS Health were worth $233,350,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Norges Bank acquired a new position in shares of CVS Health in the 2nd quarter worth approximately $1,358,698,000. Invesco Ltd. raised its position in CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the last quarter. Kingstone Capital Partners Texas LLC acquired a new position in CVS Health in the second quarter worth $155,185,000. Jennison Associates LLC grew its holdings in shares of CVS Health by 111.7% during the second quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock worth $276,895,000 after purchasing an additional 2,117,798 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of CVS Health by 1.7% in the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after buying an additional 2,063,737 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS stock opened at $80.32 on Tuesday. CVS Health Corporation has a twelve month low of $44.92 and a twelve month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The company has a market cap of $101.96 billion, a P/E ratio of 211.37, a price-to-earnings-growth ratio of 0.74 and a beta of 0.48. The business’s fifty day moving average is $78.63 and its 200-day moving average is $73.55.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the prior year, the company posted $1.09 earnings per share. The firm’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CVS. Barclays increased their price objective on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Royal Bank Of Canada reissued an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. JPMorgan Chase & Co. upped their price objective on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Wolfe Research lifted their target price on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Finally, Morgan Stanley upped their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $94.67.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.